FOSFOLAG

This brand name is authorized in Nigeria.

Active ingredients

The drug FOSFOLAG contains one active pharmaceutical ingredient (API):

1	Fosfomycin UNII 7FXW6U30GY - FOSFOMYCIN TROMETHAMINE
	Fosfomycin exerts a bactericidal effect on proliferating pathogens by preventing the enzymatic synthesis of the bacterial cell wall. Fosfomycin inhibits the first stage of intracellular bacterial cell wall synthesis by blocking peptidoglycan synthesis.
	Read more about Fosfomycin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-1624	Powder for suspension	Fosfolag Powder for Oral Suspension PWD_F_SOL 3 g 3 g x 1's (in sachet)	Granules for oral solution in sachet. Sachets are four layers laminate of: surlyn/aluminium/low-density polyethylene/paper. Sachets are supplied in cardboard outer containing 1 sachet	25/02/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01XX01	Fosfomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XX Other antibacterials
Discover more medicines within J01XX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-1624